January 25, 2023 02:22 PM EST

NIH associate director announces departure to private sector, joining anti-aging biotech

Paul Schloesser

Associate Editor

The associate director of the National Institute of Health’s Office of Legislative Policy and Analysis (OLPA) is leaving her government post to join CEO James …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

NIH associate director announces departure to private sector, joining anti-aging biotech

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

NIH as­so­ciate di­rec­tor an­nounces de­par­ture to pri­vate sec­tor, join­ing an­ti-ag­ing biotech

Associate Editor

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

NIH associate director announces departure to private sector, joining anti-aging biotech